A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine

NCT03806595 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Migraine in Children
Posttraumatic Headache

Interventions

DRUG: Lidocaine 2% Injectable Solution
DRUG: Normal Saline Flush, 0.9% Injectable Solution

Sponsor

University of British Columbia